Research Projects Page

Since our inception as an outcome committee in 2015, we have consistently and considerably expanded our ability to produce rigorous outcomes research. In 2018, we established a more formal program and leadership, including full time outcomes research staff. The result of these allocated resources has been a productive output across multiple specialty disease states. Below are highlighted outcomes from studies completed in recent years.

Research Project List

Filter
Research categories (field_research_categories)
Filter
Research categories (field_research_categories)
21-30 of 144 results

Expediting specialty medication appeals

This quality improvement project assessed implementation of a letter template to expedite appeal letter submission. Pre-implementation, 29% of appeals were submitted within 3 days of PA denial, 70% within 7 days, 88% within 14 days, and 100% within 35 days. Postimplementation 89% of appeals were submitted within 3 days, 97% within 7 days, and 100% within 14 days. Appeal approval rates were high at 93% in both the pre-implementation and postimplementation groups.

Navigating Specialty Treatment for Dermatologic Inflammatory Conditions: Patient Journey and Treatment Persistence

Preventing Disease Progression: Using a Digital Tool to Identify and Intervene on Patients with Worsening Patient Reported Outcomes in Inflammatory Bowel Disease

Specialty Pharmacy Education: A Rare Specialty in Pharmacy CurriculumG

The Impact of an Integrated Outpatient Specialty Neurology Pharmacist in a Non-MS Clinical Setting

Real-World Dosing of Abemaciclib: One-Year Evaluation of Off-Label Dosing and Modifications

United in Care: A Modified Delphi Journey to Determine Meaningful Reporting Measures in Specialty Pharmacy

Health Disparities Among Patients with Moderate to Severe Asthma in a Health System with Specialty Pharmacy: A retrospective chart review

This study describes differences in asthma-related clinical outcomes by race in patients initiating biologic therapy. There was a difference in clinic engagement between groups based on race. Cancellations were higher in patients that identify as White, and no shows were higher in patients that identify as Black or African American/Other. Identifying barriers that lead to reduced clinical engagement may allow for improved health in these patients.

Pharmacist Intervention Cost Avoidance

This study evaluates health-system specialty pharmacy (HSSP) pharmacists' roles in medication discontinuations, switches, and dose changes, focusing on cost avoidance. HSSP pharmacists intervene to ensure safe and effective use of specialty medications, preventing unnecessary costs. Pharmacists successfully avoided $129,705 - $162,133 in direct costs through their interventions. These findings support the employment and role of pharmacists in HSSPs, extending beyond prescription filling.

Redesigning Specialty Pharmacist Intervention Documentation

The purpose of the project is to redesign and align the specialty pharmacy Pharmacist Intervention (PI) Assessment with pharmacy organizations, published literature, and pharmacist feedback, allowing detailed documentation that clearly communicates the reason for and outcome of the pharmacist intervention. Key lessons learned are featured to outline steps for replicating the project in other health systems.